Tumor antigens and vaccines in colorectal cancer
Colorectal cancer (CRC) is a common cancer in the world and also has a high death rate. It is reported that vaccination is a great strategy for CRC. CRC vaccines are based on CRC tumor antigens, including tumor-associated antigens like CEA, MUC-1, CTAs and tumor-specific antigens including personali...
Main Authors: | Zhongen Wu, Mengxuan Yang, Yiou Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Medicine in Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098622000252 |
Similar Items
-
Cancer Vaccines: Antigen Selection Strategy
by: Yue Zhao, et al.
Published: (2021-01-01) -
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
by: Lu Diao, et al.
Published: (2023-08-01) -
CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information Exploration
by: Jijun Yu, et al.
Published: (2022-05-01) -
Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen
by: Michael Babich, et al.
Published: (2022-03-01) -
Lack of shared neoantigens in prevalent mutations in cancer
by: Concetta Ragone, et al.
Published: (2024-04-01)